A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers

Introduction: Over 50% of patients with colorectal cancer (CRC) will progress and/or develop metastases. Biomarkers capable of predicting progression, risk stratification and therapeutic benefit are needed. Cancer stem cells are thought to be responsible for tumor initiation, dissemination and treat...

Full description

Bibliographic Details
Main Authors: Langan, Russell C., Mullinax, John E., Ray, Satyajit, Raiji, Manish T., Schaub, Nicholas, Xin, Hong-Wu, Koizumi, Tomotake, Steinberg, Seth M., Anderson, Andrew, Wiegand, Gordon, Butcher, Donna, Anver, Miriam, Bilchik, Anton J., Stojadinovic, Alexander, Rudloff, Udo, Avital, Itzhak
Format: Online
Language:English
Published: Ivyspring International Publisher 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366478/